Acadian Asset Management LLC lifted its stake in shares of Dolby Laboratories (NYSE:DLB - Free Report) by 0.6% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,140,821 shares of the electronics maker's stock after purchasing an additional 6,953 shares during the period. Acadian Asset Management LLC owned 1.20% of Dolby Laboratories worth $91,602,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also made changes to their positions in DLB. Alpine Bank Wealth Management acquired a new stake in shares of Dolby Laboratories during the 1st quarter worth approximately $25,000. Cheviot Value Management LLC acquired a new stake in shares of Dolby Laboratories during the 1st quarter worth approximately $27,000. MAI Capital Management increased its holdings in shares of Dolby Laboratories by 87.1% during the 1st quarter. MAI Capital Management now owns 348 shares of the electronics maker's stock worth $28,000 after buying an additional 162 shares during the last quarter. Caitong International Asset Management Co. Ltd acquired a new stake in shares of Dolby Laboratories during the 1st quarter worth approximately $29,000. Finally, Global X Japan Co. Ltd. acquired a new stake in shares of Dolby Laboratories during the 1st quarter worth approximately $51,000. Institutional investors and hedge funds own 58.56% of the company's stock.
Analyst Upgrades and Downgrades
A number of brokerages have recently issued reports on DLB. Rosenblatt Securities restated a "buy" rating and set a $95.00 price target on shares of Dolby Laboratories in a report on Friday, August 1st. Wall Street Zen upgraded shares of Dolby Laboratories from a "hold" rating to a "buy" rating in a report on Saturday, August 30th. Tigress Financial raised their price target on shares of Dolby Laboratories from $112.00 to $114.00 and gave the stock a "buy" rating in a report on Friday, August 15th. Robert W. Baird initiated coverage on shares of Dolby Laboratories in a report on Friday, September 5th. They issued a "neutral" rating and a $74.00 target price for the company. Finally, Barrington Research reiterated an "outperform" rating and issued a $100.00 target price on shares of Dolby Laboratories in a report on Friday. Three research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company's stock. According to MarketBeat.com, Dolby Laboratories currently has a consensus rating of "Moderate Buy" and a consensus target price of $95.75.
Read Our Latest Stock Report on Dolby Laboratories
Dolby Laboratories Trading Down 0.9%
Dolby Laboratories stock traded down $0.63 during trading on Friday, hitting $71.48. The company had a trading volume of 337,864 shares, compared to its average volume of 440,754. Dolby Laboratories has a 1-year low of $68.24 and a 1-year high of $89.66. The company's 50 day simple moving average is $73.73 and its 200-day simple moving average is $75.53. The stock has a market cap of $6.85 billion, a price-to-earnings ratio of 26.18 and a beta of 0.93.
Dolby Laboratories (NYSE:DLB - Get Free Report) last posted its earnings results on Thursday, July 31st. The electronics maker reported $0.78 earnings per share for the quarter, beating the consensus estimate of $0.72 by $0.06. The firm had revenue of $315.55 million during the quarter, compared to the consensus estimate of $305.23 million. Dolby Laboratories had a net margin of 19.62% and a return on equity of 11.52%. The firm's revenue for the quarter was up 9.2% on a year-over-year basis. During the same quarter last year, the firm earned $0.71 EPS. Dolby Laboratories has set its FY 2025 guidance at 3.880-4.030 EPS. Q4 2025 guidance at 0.610-0.760 EPS. As a group, analysts forecast that Dolby Laboratories will post 2.94 earnings per share for the current fiscal year.
Dolby Laboratories Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Wednesday, August 20th. Shareholders of record on Tuesday, August 12th were paid a $0.33 dividend. The ex-dividend date was Tuesday, August 12th. This represents a $1.32 annualized dividend and a dividend yield of 1.8%. Dolby Laboratories's payout ratio is 48.35%.
Insider Buying and Selling at Dolby Laboratories
In other Dolby Laboratories news, CEO Kevin J. Yeaman sold 39,875 shares of the business's stock in a transaction on Tuesday, July 15th. The shares were sold at an average price of $74.82, for a total value of $2,983,447.50. Following the completion of the transaction, the chief executive officer owned 114,725 shares in the company, valued at $8,583,724.50. The trade was a 25.79% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, SVP Shriram Revankar sold 7,000 shares of the business's stock in a transaction on Friday, August 22nd. The stock was sold at an average price of $74.92, for a total transaction of $524,440.00. Following the completion of the transaction, the senior vice president owned 70,435 shares of the company's stock, valued at approximately $5,276,990.20. This trade represents a 9.04% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 99,366 shares of company stock valued at $7,352,963. Insiders own 38.39% of the company's stock.
Dolby Laboratories Profile
(
Free Report)
Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.
Featured Articles

Before you consider Dolby Laboratories, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Dolby Laboratories wasn't on the list.
While Dolby Laboratories currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.